Transcripts Exagen Inc.

Equities

Market Closed - Nasdaq Other stock markets 21:00:00 27/06/2024 BST			5-day change	1st Jan Change
1.85 ^USD	-0.54%		-5.61%	-7.04%

05-14	Cantor Fitzgerald Adjusts Price Target on Exagen to $7 From $5, Maintains Overweight Rating	MT
05-13	Exagen Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024	CI

Transcript : Exagen Inc., Q1 2024 Earnings Call, May 13, 2024	05-13
Transcript : Exagen Inc., Q4 2023 Earnings Call, Mar 18, 2024	03-18
Transcript : Exagen Inc., Q3 2023 Earnings Call, Nov 13, 2023	11-13
Transcript : Exagen Inc., Q2 2023 Earnings Call, Aug 07, 2023	07/08/23
Transcript : Exagen Inc., Q1 2023 Earnings Call, May 15, 2023	15/05/23
Transcript : Exagen Inc., Q4 2022 Earnings Call, Mar 20, 2023	20/03/23
Transcript : Exagen Inc., Q3 2022 Earnings Call, Nov 14, 2022	14/11/22
Transcript : Exagen Inc., Q2 2022 Earnings Call, Aug 04, 2022	04/08/22
Exagen Inc. Provides Revenue Guidance for the Year of 2022	04/08/22	CI
Transcript : Exagen Inc., Q1 2022 Earnings Call, May 11, 2022	11/05/22
Transcript : Exagen Inc., Q4 2021 Earnings Call, Mar 22, 2022	22/03/22
Exagen Inc. Provides Revenue Guidance for the Full Year 2022	22/03/22	CI
Transcript : Exagen Inc., Q3 2021 Earnings Call, Nov 10, 2021	10/11/21
Exagen Inc. Provides Revenue Guidance the Full Year 2021	10/11/21	CI
Transcript : Exagen Inc., Q2 2021 Earnings Call, Aug 09, 2021	09/08/21
Exagen Inc. Re-Affirms Revenue Guidance for the Year 2021	09/08/21	CI
Transcript : Exagen Inc., Q1 2021 Earnings Call, May 11, 2021	11/05/21
Exagen Inc. Provides Earnings Guidance for the Fiscal Year 2021	11/05/21	CI
Transcript : Exagen Inc., Q4 2020 Earnings Call, Mar 16, 2021	16/03/21
Exagen Inc. Provides Revenue Guidance for the Full Year 2021	16/03/21	CI

No results for this search